Literature DB >> 8910619

Regions flanking exon 1 regulate constitutive expression of the human antithrombin gene.

F A Fernandez-Rachubinski1, J H Weiner, M A Blajchman.   

Abstract

We have identified cis-acting elements and trans-acting factors that regulate constitutive expression of the human antithrombin gene. The activity of the sequences flanking the first exon of the gene was investigated using a luciferase-based reporter assay in transiently transfected HepG2, COS1, BSC40, and HeLa cells. Deletion analysis allowed the mapping of two elements able to promote antithrombin gene transcription in HepG2 and COS1 cells. The first element is located upstream of the first exon (-150/+68 nucleotides). The second element is in the first intervening sequence (+300/+700 nucleotides) and functions in an orientation opposite to that of the first. Footprint analysis showed three protected areas in the 5' upstream element at -92/-68 (element A), -14/+37 (element B), and -126/-100 nucleotides (element C). These elements acted as enhancers in luciferase reporter assays. Gel retardation analysis demonstrated that two liver-enriched transcription factors, hepatocyte nuclear factor 4 (HNF4) and CCAAT enhancer-binding protein (C/EBPa), bound to the 5' upstream element. HNF4 bound to elements A and C, whereas C/EBPa bound to element B. Element A also interacted with the ubiquitous nuclear hormone receptors chicken ovalbumin upstream promoter transcription factor 1 (COUP-TF1), thyroid hormone receptor alpha (TRalpha), peroxisome proliferator-activated receptor alpha(PPARalpha), and retinoid X receptor alpha (RXRalpha). In HepG2 and BSC40 cells, HNF4, C/EBPalpha, and RXRalpha activated luciferase expression from a reporter construct containing the 5'-upstream minimal antithrombin gene promoter, while COUP-TF1, TRalpha, and HNF3 (alpha or beta) repressed such expression. Our results show that constitutive expression of the human antithrombin gene depends in part upon the interplay of these transcription factors and suggest that signaling pathways regulated by these factors can modulate antithrombin gene transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910619     DOI: 10.1074/jbc.271.46.29502

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

1.  Regulation of the human protein C inhibitor gene expression in HepG2 cells: role of Sp1 and AP2.

Authors:  T Hayashi; M Usui; J Nishioka; Z X Zhang; K Suzuki
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

2.  Modulation of mouse coagulation gene transcription following acute in vivo delivery of synthetic small interfering RNAs targeting HNF4α and C/EBPα.

Authors:  Huma Safdar; Ka Lei Cheung; Hans L Vos; Frank J Gonzalez; Pieter H Reitsma; Yusuke Inoue; Bart J M van Vlijmen
Journal:  PLoS One       Date:  2012-06-01       Impact factor: 3.240

3.  Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium.

Authors:  Vicente Muedra; Lucrecia Moreno; Vicente Rodilla; Cristina Arce; Fermi Montó; Águeda Blázquez; Paloma Pérez; Pilar D'Ocón
Journal:  Front Pharmacol       Date:  2018-09-25       Impact factor: 5.810

4.  MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha.

Authors:  Salam Salloum-Asfar; Ana B Arroyo; Raúl Teruel-Montoya; Nuria García-Barberá; Vanessa Roldán; Vicente Vicente; Constantino Martínez; Rocío González-Conejero
Journal:  PLoS One       Date:  2016-05-02       Impact factor: 3.240

5.  Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency.

Authors:  Mara Toderici; María Eugenia de la Morena-Barrio; José Padilla; Antonia Miñano; Ana Isabel Antón; Juan Antonio Iniesta; María Teresa Herranz; Nuria Fernández; Vicente Vicente; Javier Corral
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.